Emcure Pharmaceuticals Q1 FY27 reports 22.8% revenue growth to ₹25,804 million, while PAT jumps 36.2% and EBITDA rises 25.8% in Q1 FY27.
Read More
Think | Create | Scale
Most Commented News
Emcure Pharmaceuticals Q1 FY27 reports 22.8% revenue growth to ₹25,804 million, while PAT jumps 36.2% and EBITDA rises 25.8% in Q1 FY27.
Read More